top of page
Abstract scientific background on a deep black canvas featuring a liquid chromatography tr
From antibody characterization to high-resolution LC–MS multi-omics and AI-driven integration, we deliver data you can trust for faster decisions.
Antibody Characterization
Peptide Mapping & Sequence Variant Analysis
Antibody structure diagram showing peptide mapping and post-translational modification analysis by LC-MS
  • Primary Sequence Verification

    • Amino Acid Confirmation

    • Sequence Variants

    • Truncations

  • Primary Sequence Verification Post-Translational Modification (PTM) Analysis

    • Oxidation & Deamidation

    • Glycosylation

    • Terminal Modifications

    • Other Modifications

  • Higher-Order Structure Insights

    • Disulfide Bond Mapping

    • Free Sulfhydryls

  • Specialized Biologics Analysis (ADCs & Biosimilars)

    • Conjugation Sites

    • Drug-to-Antibody Ratio (DAR)

    • Biosimilar Comparability

  • Quality Control and Stability​

    • Fingerprinting for Identity

    • Comparability

    • Degradation Pathways

Metabolomics Analysis
LC–MS Metabolite Profiling for Biomarkers and Biological Insight
  • Discovery Metabolomics

    • Broad metabolite profiling

    • Comparative study analysis

    • Metabolic signature discovery

  • Targeted Metabolomics

    • Defined metabolite panels

    • Quantitative assay support

    • Validation-focused workflows

  • Sample & Study Support

    • Plasma, serum, urine, and other biofluids

    • Tissue, cell lysates, and culture media

    • Time-course and treatment-response studies

  • Interpretation & Reporting

    • Differential metabolite analysis

    • Pathway and network interpretation

    • Multi-omics integration

    • Decision-ready deliverables

metabolomics_vector-1.png
Mass Spectrometry Solutions
Multi-Omics & Bioanalysis 
LC-MS chromatogram illustrating mass spectrometry workflows for proteomics and bioanalytical analysis
  • Single and integrated omics including proteomics, metabolomics, and lipidomics and other costumized omics.

  • Quantitative bioanalysis supports PK/PD studies from discovery through clinical phases

  • Intact and Peptide-Level Characterization

  • Targeted Quantitative Assays and Panels

  • Method Development, Transfer, and Troubleshooting

  • Small-Molecule Bioanalysis (PK/PD)

  • Biomarker Discovery and Validation

  • High-Throughput Pharmacokinetics

AI Multi-Omics Analysis 
​Next-Gen Data Integration & Interpretation
AI-driven multi-omics analysis diagram integrating proteomics, metabolomics, and data interpretation
  • Raw data is just the beginning. Our proprietary AI framework integrates diverse datasets to reveal hidden biological correlations, predict clinical outcomes, and visualize complex pathways.

  • Automated Data Pre-processing

  • Pattern Recognition & Clustering

  • Predictive Modeling for Drug Efficacy

  • Interactive Visualization Dashboards

EV Multi-Omics Platform
​From extracellular vesicle isolation to integrated biological insight
  • EV Isolation 

    • High-purity EV enrichment

    • Rapid LNP magnetic bead-based workflow

    • Compatible with plasma, serum, CSF, and cell culture media

  • EV RNA & DNA Analysis

    • Small RNA / miRNA profiling

    • Total RNA-seq and gene fusion analysis

    • ddPCR, NGS panels, copy number variation, and DNA methylation analysis

  • EV Proteomics Analysis

    • High-sensitivity EV protein profiling

    • LC–MS/MS, Olink / NuLISA, ELISA, and Western blot support

    • Cytokine and signaling pathway analysis

  • Integrated Multi-Omics Interpretation

    • RNA, DNA, and protein data integration

    • Biomarker discovery and validation

    • Pathway, network, and AI-supported interpretation

    • Custom reports and visualization

  • Research Applications

    • Liquid biopsy research

    • Disease mechanism studies

    • MRD and treatment-response monitoring

    • Drug response monitoring

    • Translational and precision medicine studies

bottom of page